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Absence of MHC-II expression by lymph node stromal cells
results in autoimmunity
Juan Dubrot1,*, Fernanda V Duraes1,*, Guillaume Harle´1,*, Anjalie Schlaeppi1 , Dale Brighouse1, Natacha Madelon1,2,
Christine Go¨pfert3 , Nadine Stokar-Regenscheit3, Hans Acha-Orbea4, Walter Reith1, Monique Gannage´1,2,
Stephanie Hugues1
How lymph node stromal cells (LNSCs) shape peripheral T-cell
responses remains unclear. We have previously demonstrated
that murine LNSCs, lymphatic endothelial cells (LECs), blood
endothelial cells (BECs), and ﬁbroblastic reticular cells (FRCs) use
the IFN-γ–inducible promoter IV (pIV) of the MHC class II (MHCII)
transactivator CIITA to express MHCII. Here, we show that aging
mice (>1 yr old) in which MHCII is abrogated in LNSCs by the
selective deletion of pIV exhibit a signiﬁcant T-cell dysregulation
in LNs, including defective Treg and increased effector CD4+ and
CD8+ T-cell frequencies, resulting in enhanced peripheral organ
T-cell inﬁltration and autoantibody production. The proliferation
of LN-Tregs interacting with LECs increases following MHCII up-
regulation by LECs upon aging or after exposure to IFN-γ, this
effect being abolished in mice in which LECs lack MHCII. Overall,
our work underpins the importance of LNSCs, particularly LECs, in
supporting Tregs and T-cell tolerance.
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Introduction
T-cell precursors undergo thymic negative selection, which ensures
the elimination of developing T cells expressing TCR-recognizing self-
Agswith excessive afﬁnity. However, some autoreactive T cells escape
this process of clonal deletion and exit the thymus to populate
secondary lymphoid organs (SLOs). Therefore, additional mecha-
nisms of T-cell tolerance are required in the periphery to avoid the
development of autoimmunity. Among them, resting DCs, which
constantly sample self-Ags in peripheral tissues and reach the
draining LNs through the afferent lymph, present self-Ag–derived
peptides to naive T cells. In the absence of danger, this phenomenon
leads to clonal deletion, or anergy of autoreactive T cells (Steinman
et al, 2003; Mueller, 2010). Alternatively, Tregs, by exhibiting sup-
pressive immunoregulatory functions, can inhibit autoreactive
T cells. Different subsets of Tregs have been described so far.
Natural Tregs bear an autoreactive TCR, are induced in the thymus,
and express the transcription factor Foxp3. Peripheral-induced
Tregs can express Foxp3 or not, and differentiate in SLOs (Chen
et al, 2003; Swee et al, 2009; Wirnsberger et al, 2011). Preservation of
Treg function and biology is crucial for peripheral tolerance.
Lymph node stromal cells (LNSCs) have recently been promoted
to the rank of new modulators of T-cell responses. After being
considered for years as simple scaffolding, forming routes, and
proper environment for Ag-lymphocyte encountering, we recently
learned that they also impact both DC and T-cell functions. Lym-
phatic endothelial cells (LECs) promote DC entry into and T-cell
egress from LNs (Sixt et al, 2005; Pham et al, 2010; Braun et al, 2011),
whereas CCL19/CCL21–producing ﬁbroblastic reticular cells (FRCs)
control immune cells entry and proper localization into LNs (Link
et al, 2007; Tomei et al, 2009). Blood endothelial cells (BECs) control
T-cell homing to LNs (Bajenoff et al, 2003). In addition, LECs and
FRCs are the major source of IL-7 in LNs, ensuring T-cell homeo-
stasis. In inﬂammatory situations, however, LECs and FRCs produce
nitric oxide to constrict T-cell expansion (Khan et al, 2011; Lukacs-
Kornek et al, 2011; Siegert et al, 2011), whereas LECs further impair DC
maturation in a contact-dependent fashion (Podgrabinska et al,
2009). In the context of peripheral tolerance, LNSCs, and in par-
ticular LECs and FRCs, ectopically express a large range of pe-
ripheral tissue Ags (PTAs), and further present PTA-derived
peptides through MHC class I (MHCI) molecules to induce self-
reactive CD8+ T-cell deletion (Cohen et al, 2010; Fletcher et al, 2010,
2011; Tewalt et al, 2012). We have previously demonstrated that, in
addition to inducing CD4+ T-cell dysfunction by presenting peptide-
MHC class II (MHCII) complexes acquired from DCs, LECs, BECs, and
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FRCs endogenously express MHCII molecules (Dubrot et al, 2014).
Central tolerance of self-reactive CD4+ T cells is partially mediated
by thymic epithelial cells (TECs), in which MHCII molecules are
loaded with peptides derived either from phagocytosis and pro-
cessing of extracellular Ags (Stern et al, 2006), or from autophagy
and endocytosis of intracellular Ags (Adamopoulou et al, 2013;
Aichinger et al, 2013). Whether these pathways can be involved in
MHCII-restricted Ag presentation by LNSCs, and impact peripheral
self-reactive T-cell responses, is currently unknown.
Here, we have used genetically modiﬁed mice in which MHCII
expression by non-hematopoietic cells is abrogated. Upon aging,
and compared with their control counterparts, these mice exhibit
an enhancement of spontaneous autoimmune processes, with
enhanced T-cell activation in SLOs and effector T-cell inﬁltration in
peripheral tissues, as well as the production of autoantibodies. In
contrast, the Treg compartment is signiﬁcantly impaired in SLOs.
Furthermore, Rag2−/− mice transferred with T cell isolated from LN
of aging MHCII-deﬁcient LNSC mice displayed similar immuno-
logical and clinical perturbations compared with recipient injected
with age-matched control T cells, suggesting a direct link between
MHCII expressed by LNSCs and the appearance of T cell–mediated
signs of autoimmunity. Accordingly, upon aging or IFN-γ treatment,
LECs up-regulate MHCII molecules, and interact with Treg to pro-
mote their proliferation. This phenotype is abolished in mice de-
ﬁcient for MHCII expression in LECs. Altogether, we prove that MHCII
expression by LNSCs have a manifest impact in peripheral toler-
ance. Notably, LECs support self-Ag–speciﬁc T cell peripheral tol-
erance by promoting Treg proliferation through MHCII-restricted Ag
presentation.
Results
Expression of MHCII by LNSCs
Our previous work has demonstrated that LNSCs impact CD4+ T-cell
biology by presenting peptide-MHCII complexes acquired from
DCs (Dubrot et al, 2014). Although these ﬁndings revealed a novel
function of the lymphoid stroma as casual APC, whether endoge-
nous MHCII Ag presentation by LNSCs can also impact T-cell
responses remains to be determined. To abrogate cell-intrinsic pIV-
mediated MHCII expression by LNSCs, we have used mice deﬁcient
for the IFN-γ–inducible pIV of CIITA (pIVKO) (Waldburger et al, 2001).
As expected, steady-state MHCII expression by LECs, BECs, and FRCs
was only partially abrogated in pIVKO mice compared with control
mice (Fig 1A). Indeed, we recently described that MHCII expression
by LNSCs partially results from a combination of both DC-acquired
and CIITA promoter IV (pIV)–driven, endogenously expressed, MHCII
molecules (Dubrot et al, 2014). DCs use the pI promoter of CIITA, and
therefore, MHCII transfer to LNSCs is not abrogated following pIV
deletion (Dubrot et al, 2014). However, pIV deletion led to the
abrogation of endogenous MHCII expression by LECs, BECs, and
FRCs. We conﬁrmed this by analysing a second CTIIA-regulated
gene, H2-M, the oligomorphic MHCII molecule involved in MHCII
Ag loading. Ex vivo LECs, BECs, and FRCs express low H2-M and
MHCII levels in the steady state, but substantially up-regulate
H2-M and I-Ab molecules at both mRNA (Fig 1B) and protein (Fig
1C) levels after IFN-γ treatment (s.c. injection), suggesting a
potential role for MHCII-restricted Ag presentation by LNSCs
during inﬂammation. Both steady state and IFN-γ–inducible
endogenous MHCII expressions were abrogated in pIVKO mice
(Fig 1B and C).
Abrogation of endogenous MHCII in LNSCs
MHCII expression in cortical TECs (cTECs) depends on pIV. Because
of the absence of MHCII expression by cTECs, pIVKO mice conse-
quently exhibit a defect in CD4+ T-cell thymic positive selection, and
lack peripheral CD4+ T cells (Waldburger et al, 2003). Therefore,
pIVKO mice were crossed with transgenic mice expressing CIITA
under the keratin 14 (K14) promoter, which is active in cTECs (Laufer
et al, 1996), but not in LNSCs (Fig 2A and B). MHCII expression by
cTECs was efﬁciently restored in K14 CIITA tg x Ciita pIV−/−
(referred as K14tgpIVKO mice) mice compared with pIVKO mice,
and to a similar extent compared with cTECs isolated from WT
or control (K14 Ciita tg × Ciita pIV+/−, referred to as K14tg) mice
(Fig 2C). As a consequence and as described before (Irla et al,
2008; Thelemann et al, 2014, 2016), K14tgpIVKO mice exhibit
normal CD4+ T-cell frequencies in SLOs (Fig 2D). We did not observe
any signiﬁcant expression of the K14 transgene in LNSCs puriﬁed
from these mice (Fig 2B). However, to avoid any off-target effect of
the K14 Ciita transgene in LNSCs or other cells, K14tgpIVKOmice were
always compared with K14tg controls in all experiments. Impor-
tantly, MHCII expression by mTECs is not altered in pIVKO and
K14tgpIVKO mice (Fig 2C), for the, respective, following reasons: ﬁrst,
mTECs express the pIII of CIITA in addition to pIV (Irla et al, 2008),
and second, the K14 promoter is not active in terminally differ-
entiated mTECs (Sukseree et al, 2012). Therefore, negative CD4+
T-cell selection is unaffected in K14tgpIVKO mice. Accordingly, we
have previously demonstrated that CD4+ thymocytes and periph-
eral CD4+ T cells that developed in K14tgpIVKO mice (6–10 wk-old)
were indistinguishable fromWTwith respect to cell numbers and TCR
V-β repertoire (Irla et al, 2008).
IFN-γ–induced endogenous and pIV-dependent MHCII up-
regulation, which was efﬁciently abolished in LECs, BECs, and
FRCs from K14tgpIVKO mice compared with control mice (Fig 2E).
However, the expression of MHCII by other LN cells, i.e., different DC
subtypes, B cells, or monocytes/macrophages, which rely on pI
and/or pIII of CIITA (Waldburger et al, 2001), was found unaffected in
K14tgpIVKO mice (Fig 2F). Altogether, our data demonstrate that
endogenous MHCII expression is efﬁciently abrogated in LNSCs of
K14tgpIVKO mice.
Mice deﬁcient for MHCII expression in LNSCs develop
spontaneous signs of T cell–mediated autoimmunity
LNSCs have been so far described to function as tolerogenic Ag-
presenting cells. Therefore, we tested whether the absence if MHCII
expression by LNSCs would result in self-reactive T-cell tolerance
breakdown and lead to immunopathology. Analysis of peripheral
organs showed that the percentage of CD4+ and CD8+ T cells in-
ﬁltrating the spinal cord (SC) and salivary glands (SGs) were
markedly increased in K14tgpIVKO compared with K14tg control
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elderly (18 mo-old) mice (Fig 3A). No difference was observed in
4-mo-old mice (Fig 3A). In addition, intestines of 18-mo-old
K14tgpIVKO exhibit increased frequencies of CD4+ T cells produc-
ing the proinﬂammatory cytokine IFN-γ compared with K14tg
controls (Fig 3B). Other peripheral organs, such as the liver and the
lungs, also exhibit a tendency of enhanced inﬁltrating CD4+ and
CD8+ T cell numbers in 18-mo-old K14tgpIVKO mice, although not
signiﬁcant (not shown). Therefore, peripheral tissue T-cell inﬁl-
tration was increased in a variety of non-lymphoid organs in elderly
K14tgpIVKO mice. In agreement with a possible autoimmune syn-
drome, serum obtained from 18-mo-old K14tgpIVKO mice contained
a broader spectrum of autoantibodies with enhanced reactivity to
proteins from several tissues compared with K14tg control mice
(Fig 3C), indicating an exacerbated development of systemic au-
toimmunity upon aging. Altogether, our data provide evidence that
MHCII molecule expression by non-hematopoietic cells contribute
to peripheral T-cell tolerance by providing a brake in the devel-
opment of spontaneous signs of T cell–mediated autoimmune
inﬂammation in peripheral tissues of elderly mice.
MHCII abrogation in LNSCs enhances T-cell activation and impairs
the Treg compartment in LNs
We next sought to determine whether exacerbated signs of T cell–
mediated autoimmune inﬂammation in peripheral tissues of elderly
K14tgpIVKO mice result from enhanced T-cell activation in SLOs.
Analysis of CD4+ and CD8+ T cells in LN did not show any differences
between 4-mo-old K14tgpIVKO and K14tg mice (Fig 4A). However, in
aging mice (18 mo), we noticed a signiﬁcant enhanced T-cell acti-
vation, with decreased frequencies of naive (CD62LhiCD44lo) and
increased frequencies of activated (CD62LloCD44hi) CD4+ and CD8+
T cells in LNs of K14tgpIVKO compared with K14tg mice (Fig 4A). In
Figure 1. LNSCs upte MHCII and MHCII-associated molecules in response to IFN-γ.
(A) Flow cytometry and plotted histograms showing MHCII expression (MFI) by LECs, BECs, and FRCs from LN of indicated naive mice. MHCII coming from DC (blue arrow)-
or endogenous (red arrow)-origin, is indicated. (B) WT or pIV CIITA–deﬁcient mice (pIVKO) mice were injected subcutaneously with PBS or 1 μg of IFN-γ; LNSCs were
sorted by ﬂow cytometry 24 h later. Histograms represent I-Aβ (upper panel) and H-2Mα (lower panel) relative mRNA expression by LECs, BECs, and FRCs from indicated
mice, measured by qPCR and normalized to GAPDH. Data are representative of two experiments with 10 mice pooled/group. (C) LNSCs and DCs from draining LNs
were analysed 24 h after IFN-γ injection (as previously) by ﬂow cytometry. Dot plots represent the expression of MHCII and H-2M by LECs, BECs, FRCs, and DCs from indicated
mice. Frequency of double positive fractions are highlighted in red. Data are representative of two experiments with three mice/group.
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addition, the frequency of effector CD4+ and CD8+ T cells expressing
PD-1, and the frequency of CD4+ and CD8+ T cells producing IFN-γ,
were enhanced in skin LNs from K14tgpIVKO compared with K14tg
mice (Fig 4B). Because both CD4+ and CD8+ T-cell phenotypes and
effector functions were affected, we postulated that an active
mechanism of T-cell inhibition might have been lost in LNs of
K14tgpIVKO mice upon aging. Accordingly, the frequency of Foxp3+
Tregs was signiﬁcantly impaired (two-fold reduction) in LNs of aging
K14tgpIVKO compared with K14tg controlmice (Fig 4C). Foxp3+ staining
on LN sections conﬁrmed this phenotype (Fig 4D). In contrast, no
difference in Treg frequencies was observed in 4-mo-old mice (Fig
4C). With Treg frequencies being reduced in aging K14tgpIVKO com-
pared with K14tg controls, we next wondered whether this cellular
population exhibited any phenotypic or functional alteration. We did
not observe any alteration in the expression of several typical
markers characterizing the Treg compartment, such as PD-1, CD44,
CD25, or Foxp3 (not shown). In contrast, compared with control mice,
LN Treg isolated from aging K14tgpIVKO mice exhibited an impaired
ability to suppress the proliferation of naive CD4+ T cells in vitro at the
Treg:Tnaive ratio of 1:5 (Fig 4E). The fact that no difference was ob-
served when increased Treg numbers were used suggests that im-
paired Treg functions in knockout mice can be overcome with high
Treg numbers.
So far, we have accumulated convincing data that upon aging,
K14tgpIVKO exhibits signs of spontaneous autoimmune defects.
Organ-inﬁltrating T cells, and also the production of autoantibodies
are increased, suggesting that the lack of MHCII expression by
LNSCs in LNs of knockout elderly is likely to be responsible for this
phenotype. However, these observations might also result from the
lack of pIV of CIITA in the target organs, as other non-hematopoietic
cells from peripheral tissues may up-regulate MHCII and contribute
to this phenotype. Indeed, peripheral tissue-resident cells can up-
regulate MHCII molecules in an IFN-γ–inducible pIV-dependent
pathway and, by re-stimulating inﬁltrating T cells, possibly inﬂu-
ence the outcome of T-cell responses (Duraes et al, 2013). Therefore,
to determine whether enhanced signs of spontaneous autoim-
munity in aging K14tgpIVKO mice were a direct consequence of
MHCII deﬁciency in LNSCs, we adoptively transferred T cells isolated
from LN of K14tgpIVKO or control K14tgmice into Rag2−/− mice. 4 mo
later, recipients that received T cells from >18-mo-old K14tgpIVKO
mice exhibited a signiﬁcant loss of weight compared with mice
injected with T cells isolated from age-matched K14tg controls (Fig
5A). Accordingly, immunoﬂuorescence staining on small intestine
sections revealed that Rag2−/− hosts that received LN T cells from
K14tgpIVKO mice exhibited increased inﬁltrating CD45+ cells, and
in particular in the CD3+ T-cell compartment (Fig 5B). In addition,
Figure 2. Selective abrogation of endogenous MHCII
expression in LNSCs.
(A) Schematic representation of K14tgpIVKOmice. Brieﬂy,
pIVKO were crossed with transgenic mice expressing the
full CIITA cDNA under the control of the keratin 14 (K14)
promoter (K14tg). (B) Relative mRNA expression of K14
by LECs, BECs, FRCs, B cells and cTEC from K14tgpIVKO
mice, measured by qPCR and normalized to GAPDH. Data
are representative of two experiments with 10 mice
pooled/group (C) Flow cytometry histograms showing
the expression of MHCII molecules by cTECs (gated on
CD45negEpCAM+Ly5.1hi cells) and mTECs (gated on
CD45negEpCAM+Ly5.1intcells) from indicated mice. (D)
Flow cytometry dot plots showing CD8+ and CD4+ T-cell
frequencies in LN of indicated mice (gated on CD3+
cells). (C, D) Data are representative of two experiments
with three mice/group. (E) Histograms showing MHCII
expression (MFI) by LECs, BECs, and FRCs from LN of
indicated mice, either naive (ﬁlled) or injected s.c. with
IFN-γ 24 h before (hatched). (F) Graphs showing MHCII
expression (MFI) by CD11b+ cDCs (CD11chiCD11b+), CD8α+
DCs (CD11chiCD8α+), pDCs (CD11cintPDCA-1+), B cells
(CD19+), andmonocytes/macrophages (CD11cneg CD11b+)
isolated from LNs of indicated mice. (E, F) Data are
representative of two experiments with 3-4 mice/group.
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frequencies of naive CD62LhiCD44lo CD4+ and CD8+ T cells were
decreased in LN of mice injected with T cells from K14tgpIVKO
donors (Fig 5C). Frequencies of effector CD4+ T cells producing IFN-γ
or IL-17 were also augmented, as well as the frequency of IFN-γ
producing CD8+ T cells, in LN of Rag2−/−mice transferred with T cells
from K14tgpIVKO mice, (Fig 5D). Again, no signiﬁcant difference was
observed when adoptively transferred T cells were isolated from
4-mo-old K14tgpIVKO or control K14tg donors (not shown). As ob-
served in donor LNs, the frequency of Foxp3+ Tregs was signiﬁcantly
reduced in LNs of recipient Rag2−/− mice injected with 18-mo-old
K14tgpIVKO compared with control K14tg T cells (Fig 5E), suggesting
that the impaired Treg compartment would account for autoim-
mune T-cell disorders. Although a role for MHCII expression by cells
in peripheral organs cannot be formally excluded, our data show
that both Treg and non-Treg cells were affected in the absence of
MHCII-restricted Ag presentation by LNSCs.
Altogether, our data suggest that MHCII expression by LNSCs
contributes to self-reactive T-cell tolerance. When abrogated, it
results in impaired Treg frequencies, enhanced self-reactive T-cell
activation, and subsequent peripheral tissue inﬁltration in elderly
mice.
Deletion of MHCII on LNSCs decreases Treg proliferation
Interestingly, the levels of expression of MHCII molecules by LECs
were signiﬁcantly higher in elderly (18 mo) compared with young
(4 mo) mice (Fig 6A). A slight, but not signiﬁcant, increase in MHCII
expression by BECs, but not by FRCs, was also observed. These
observations can be a consequence of increased levels of IFN-γ in
old versus young LNs, (although undetectable by ELISA, not shown)
and/or an enhanced sensitivity to IFN-γ. Accordingly, LECs and BECs
express higher levels of IFN-γ receptor in LNs from elderly com-
pared with younger mice (Fig 6A). These results suggest a more
substantial contribution of MHCII-restricted Ag presentation by
LECs in aging mice, and provide a possible explanation of why the
phenotype observed in K14tgpIVKO only appeared after several
months.
Treg frequencies were found impaired in aging (18 mo), but not in
young adult (4 mo) K14tgpIVKO mice lacking MHCII expression in
LNSCs. Therefore, we tested whether Treg proliferation may be
affected by the loss of MHCII expression in LECs. Immunoﬂuores-
cence staining on LN sections from K14tgpIVKO and control elderly
showed that the frequency of proliferating (red, Ki67+) Tregs (green,
Foxp3+) in close interaction with LECs (Lyve-1+, in white) was sig-
niﬁcantly increased in aging controls compared with K14tgpIVKO
mice (Fig 6B).
We next tested whether IFN-γ stimulation, which promotes MHCII
up-regulation in LNSCs, could accelerate this phenotype. WT mice
were injected or not with IFN-γ, together with FTY720, which inhibits
T-cell egress from LNs (Cyster & Schwab, 2012), and LECs and Treg
were analysed in LNs 6 d after IFN-γ injection. Immunoﬂuorescence
staining revealed that the frequency of proliferating (red, Ki67+)
Tregs (green, Foxp3+) in close interaction with LECs (Lyve-1+, in
white) was signiﬁcantly increased in mice treated with IFN-γ com-
pared with untreated mice (Fig 6C). Again, to determine whether
increased Treg expansion in LNs following IFN-γ injection was
dependent on MHCII expression by LNSC, most likely by LECs, we
performed similar experiments in K14tgpIVKO and K14tg control
Figure 3. Aging K14tgpIVKO mice exhibit enhanced
effector T-cell inﬁltration in peripheral organs and
increased levels of autoantibodies.
(A) K14tgpIVKO (white) and K14tg control mice (black)
were analysed at 4 and 18 mo. Percentages of inﬁltrating
CD4+ (upper) and CD8+ (lower) T cells in SC and SGs from
K14tgpIVKO and control K14tgmice at the indicated ages.
Data are pooled from ﬁve individual mice. (B) Flow
cytometry analyses of cytokine production by inﬁltrating
CD4+ T cells in the intestine of 18-mo-old K14tgpIVKO and
control K14tgmice. Data are pooled from four individual
mice and are representative of two experiments. (C) Sera
from 18-mo-old K14tgpIVKO and control mice were
individually tested for antibody reactivity against organ-
speciﬁc proteins in immunoblots loaded from left to
right; the liver (Li), brain (Br), lung (Lu), kidney (Kd), SC,
SGs, heart (He), and Gut. Representative examples are
shown. Colored circles represent the intensity of serum
reactivity in the immunoblots. Data are pooled from ﬁve
individual mice. Two-way Anova; *P < 0.05; **P < 0.01; n.s.,
not signiﬁcant. Error bars depict mean ± SEM.
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mice. We observed an increased Treg proliferation in LNs of K14tg
controls, and further demonstrated that proliferating (red, Ki67+)
Tregs (green, Foxp3+) (red arrows) in close proximity of LECs (white,
Lyve-1+) (Fig 6C). In contrast, Treg proliferation in LEC proximity (red
arrows) was lower in LNs of K14tgpIVKOmice, demonstrating that the
increase of proliferation of Tregs interacting with LECs was de-
pendent on their expression of MHCII (Fig 6C). In contrast, we did
not observe any increase in the proliferation of non-Treg (Foxp3neg)
CD4+ T cells upon IFN-γ stimulation, nor difference between K14tg
controls and K14tgpIVKO mice (not shown), suggesting that the Treg
compartment is speciﬁcally affected. Finally, to examine a potential
direct contribution of LECs as MHCII-restricted APCs in inducing
Treg proliferation, we repeated the above experiments in mice in
which MHCII expression was selectively abrogated in LECs. For that,
we used Prox-1-CreERT2 mice, expressing the Tamoxifen-inducible
Cre recombinase under the promoter Prox-1, which is selectively
expressed in adult LECs (Bazigou et al, 2011). Prox-1-CreERT2 mice
were crossed with MHCIIﬂ mice, allowing the selective deletion of
MHCII molecules in LECs upon Tamoxifen treatment (not shown).
Immunoﬂuorescence analyses of LN sections demonstrated that
the frequency of proliferating Tregs in contact with LECs 6 d after
IFN-γ injection was signiﬁcantly reduced in mice in which LECs do
not express MHCII molecules (Prox-1-CreERT2 MHCIIﬂ) compared with
control mice (MHCIIﬂ) (Fig 6D). Altogether, our results demonstrate
that IFN-γ–mediated MHCII up-regulation by LNSCs promotes Treg
proliferation, with a major contribution of LECs.
Discussion
Our results provide the ﬁrst evidence for an in vivo role of LNSCs in
impacting peripheral T-cell tolerance as MHCII-restricted APCs.
We have recently published that subsets of murine LNSCs present
MHCII–peptide complexes acquired from DCs to induce CD4+ T-cell
dysfunction (Dubrot et al, 2014). Here, we further show that LNSCs
inhibit autoreactive T-cell responses by directly presenting Ags
through endogenous MHCII molecules. A recent study suggested
that, although LECs express surface MHCII molecules, they
cannot present a model Ag to CD4+ T cells presumably because of
the lack of expression of H2-M in steady state, preventing the
Figure 4. K14tgpIVKO mice exhibit enhanced T-cell
activation and impaired Treg frequencies in LNs upon
aging.
K14tgpIVKO (white) and K14tg control mice (black) were
analysed at 4 and 18 mo. (A) Frequencies of naive
(CD62LhiCD44lo) and activated/memory (CD62LloCD44hi)
CD4+ and CD8+ T cells. (B) Frequencies of PD-1+, IFN-γ,
and IL-17 producing cells among CD4+ and/or CD8+
T cells. (C, D) Foxp3+ Treg identiﬁcation by ﬂow
cytometry (CD4+ CD25+ Foxp3+) (C) and IHC staining
(Foxp3+) (D) in lymph nodes of indicated mice. (A–D)
Data are representative of three experiments with 3–7
mice/group. *P < 0.05; **P < 0.01; ***P < 0.001; n.s., not
signiﬁcant. Error bars depict mean ± SEM. (E) CD4+ CD25hi
T cells (Treg) from total skin LNs of 18-mo-old
K14tgpIVKO and K14tg mice were cultured (ratio 1:5, 1:3,
and 1.1) with proliferation dye-labeled naive CD4+
CD25neg T cells. Labeled T-cell proliferation was
assessed by ﬂow cytometry after 5 d of co-culture. Data
are representative of two experiments. Two-way Anova;
**P < 0.01.
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loading of endogenous antigenic peptides onto MHCII molecules
(Rouhani et al, 2015). However, we show that LECs, BECs, and FRCs
that express the IFN-γ–inducible-CIITA pIV, require IFN-γ to up-
regulate H-2M molecules, as they do for MHCII expression, these
two genes being co-regulated by CIITA (Reith & Mach, 2001). In
addition, LNSCs were described to express considerable amounts
of invariant chain (Ii) and cathepsin L (Rouhani et al, 2015), and
therefore seem well equipped for the presentation of antigenic
peptides through MHCII in situations involving the presence
of IFN-γ.
Genetic abrogation of MHCII in LNSCs in vivo leads to impaired
regulatory T-cell frequencies and in vitro functions, enhanced
effector T cell differentiation LNs and peripheral tissue inﬁltration,
and subsequent development of T cell–mediated autoimmunity in
elderly mice. Indeed, mice lacking MHCII in LNSCs exhibit spon-
taneous signs of autoimmunity in elderly mice. LNSCs express a
broad range of self-Ags. Therefore, our hypothesis is that abro-
gation of MHCII in these cells will lead to an inﬂation of polyclonal
memory/effector T cells. In agreement, no difference was observed
in the frequency of several TCR Vβ chains expressed by CD4+ and
CD8+ T cells isolated from LNs of old control and knockout mice (not
shown), suggesting that there is no restriction of T-cell clonality in
mice lacking MHCII in LNSCs. Importantly, in this model there is no
pre-existing early CD4+ T-cell bias, nor Treg function impairment.
K14tgpIVKO young adult mice do not present any abnormality, ex-
cluding the possibility of a defect from thymic selection. In addition,
T cells from 6- to 10-wk-old K14tgpIVKO mice were recently ex-
tensively characterized, and normal distribution of CD4+ naive,
effector, and Foxp3+ T-cell subsets were observed in the thymus,
spleen, and peripheral LNs (Thelemann et al, 2014).
In contrast to a recent study suggesting an activity of K14 pro-
moter in LNSCs (Baptista et al, 2014), we did not observe any K14
mRNA expression in LECs, BECs, and FRCs (Fig 2B). Consistently,
MHCII expression was similar in LNSCs isolated from pIVKO and
K14tgpIVKO mice (Fig 2E), conﬁrming that the K14 ciita transgene
does not promote any MHCII expression in LNSCs. However, be-
cause peripheral non-hematopoietic tissue-resident cells can up-
regulate MHCII molecules in an IFN-γ–inducible pIV-dependent
manner (Duraes et al, 2013), this mouse model does not repre-
sent per se a valid mouse model to study the speciﬁc role of
endogenous MHCII expression by LNSCs in shaping peripheral CD4+
T-cell responses. For instance, intestinal epithelial cells (IECs),
hepatocytes and liver sinusoidal endothelial cells, pancreatic
β cells, or astrocytes were postulated to be capable of MHCII-
mediated Ag presentation, although very little in vivo data are
available on the potential impact on peripheral CD4+ T-cell re-
sponses (reviewed in Duraes et al [2013]). Recently, using themouse
model we are presently exploiting, two studies have highlighted
opposite roles for MHCII expression in distinct target tissues.
First, IFN-γ–mediated MHCII up-regulation by IECs exerts anti-
inﬂammatory effects and protect against colitis (Thelemann
et al, 2014). In contrast, in the context of experimental autoim-
mune myocarditis, elevated IFN-γ–inducible cardiac endothelial
MHCII expression exacerbates the disease (Thelemann et al, 2016).
Together, these ﬁndings provide evidence of a critical role of pIV-
mediated non-hematopoietic MHCII expression in peripheral tissues
Figure 5. T cells isolated from mice lacking MHCII
expression in LNSCs induce autoimmunity upon
transfer into immunodeﬁcient mice.
(A–E) T cells isolated from LNs and spleen of 18-mo-old
K14tgpIVKO (white) and control mice (black) were
adoptively transferred into Rag2−/− recipient mice that
were analysed 4 mo later. (A) Mouse weight. Data are
pooled from four mice and representative of two
experiments. (B) Sections of small intestines from
recipient Rag2−/− mice were stained with antibodies
against CD45 (green), CD3 (red), and with DAPI (blue).
Pictures show representative tissue sections. Graphs
represent the quantiﬁcation of CD3+ T cells/area and
are pooled from 12 tissue sections from three individual
mice/group. (C–E) Flow cytometry dot plots showing
the frequency of CD62LhiCD44lo CD4+ and CD8+ T cells
(C), the frequency of CD4+ T cell–producing IFN-γ or IL-17
and the frequency of CD8+ T cell–producing IFN-γ in LNs
(D) and Treg frequencies (E) in LNs of transferred Rag2−/
− recipient mice. Data are representative of two
experiments with 2–4 mice/group each. (C–E) *P < 0.05;
**P < 0.01; ***P < 0.001; n.s. (A, B, D) unpaired t test, (C, E)
two-way Anova.
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upon inﬂammation, the impact on T-cell responses being largely
dependent on the target organ. Here, we add a distinct role of LN-
resident stromal populations in shaping CD4+ T-cell responses,
providing support to Treg homeostasis and maintaining peripheral
tolerance. We cannot totally exclude a role for a lack of MHCII
expression by cells in peripheral tissue on local T-cell reactivation
in K14tgpIVKO mice. Indeed, it is possible that T cells inﬁltrating
peripheral organs are maintained in a tolerogenic state by local
MHCII+ cells, and that this phenomenon is abrogated in our mouse
model. However, it is unlikely, for several reasons. First, a similar
phenotype was obtained after adoptive transfer of T cells from LN
of K14tgpIVKO mice into Rag2−/− with competent MHCII peripheral
tissues. Importantly, T-cell compartments in the recipient Rag2−/−
mice recapitulated the effects observed in the donor transgenic
mice indicating a contribution of LNSCs to peripheral T-cell al-
terations. Second, although a contribution of MHCII expression by
tissue-resident cells has been described before, it was always in
inﬂammatory settings, in which these cells indeed up-regulate
MHCII in contrast to our stud which was performed in the steady
state (Duraes et al, 2013), minimizing their possible contribu-
tion as MHCII-restricted Ag presenting cells in the absence of
model-induced inﬂammation. Finally, LN-resident Tregs exhibit
impaired proliferation in LNs not only in K14tgpIVKO, but also in
Prox-1-CreERT2 MHCIIﬂ mice, supporting a pro-tolerogenic role for
MHCII-restricted Ag presentation by LNSCs, in particular LECs, in
dampening T-cell autoimmune reactions.
We have previously shown that endogenous MHCII expression by
LECs, BECs, and FRCs was signiﬁcantly increased inWTmice compared
to IFN-γ receptor–deﬁcient mice (Dubrot et al, 2014), demonstrating
that the presence of low levels of IFN-γ in naive mice drives pIV-
mediated MHCII endogenous expression in steady-state LNSCs. This
was conﬁrmed by reduced MHCII expression by LNSCs in steady-state
Figure 6. Deletion of MHCII on LECs decreases Treg
proliferation.
(A)MHCII and IFN-γ receptor (IFNγR) expression (MFI) by
LECs, BECs, and FRCs from LN of WT mice of the
indicated age. Data are representative of two
experiments with three mice/group each. (B–D) LN
sections depicting LECs (Lyve-1, white) and proliferating
Tregs (red arrows) (Ki67, red; and Foxp3, green) from 18-
mo-old K14tg and K14tgpIVKO mice (B), 3-mo-old WT and
K14tg and K14tgpIVKO (C), and 3-mo-old Tamoxifen-
treated Prox-1-CreERT2 MHCIIﬂ and MHCIIﬂ control mice
(D). In (C) and (D), animals were treated with FTY720
every day for the last 6 d, and with IFN-γ 6 d before
harvesting the LNs. Graphs represent the percentages
of Ki67+ among Foxp3+ cells in contact with LECs from LN
of the indicated mice. (B–D) Data are pooled from at
least nine tissue sections from three individual mice/
group. *P < 0.05; **P < 0.01; ***P < 0.001; n.s. (A, C) Two-
way Anova, (B, D) unpaired t test.
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LNs from K14tgpIVKO compared with control mice. Therefore, basal
(and presumably variable) levels of circulating steady-state IFN-γ
promote endogenous MHCII expression by LNSCs, and confer them
the ability to function as competent MHCII-mediated APCs. Increased
inﬂammatory status over time might be due to the accumulation of
punctual and mild infectious processes or altered gut microbiotic
composition upon aging (Claesson et al, 2012).
Last, we provide evidence for a direct effect of MHCII-restricted Ag
presentation by LECs in promoting Treg proliferation. Genetic selective
abrogation of MHCII expression by LECs in mice results, similarly to
whatwas observed in K14tgpIVKOmice, in impaired proliferation of Treg
in contact with LECs. Therefore, among the LNSC subsets, LECs seems
to be themain contributors in inducing Treg proliferation. Distinct sets
of PTA expression, together with differential levels of expression of co-
inhibitory molecules, such as PDL-1 (Tewalt et al, 2012), by LNSC
populations might give rise to distinct impacts on T-cell responses,
such as T-cell apoptosis, T-cell anergy, or Treg induction. Elevated PDL-1
expression by LECs compared with BECs and FRCs might explain a role
for those cells in impacting Tregs, which express high levels of PD-1.
Although we did not elucidate the molecular mechanisms, a se-
lective effect on Tregs, which mostly express a self-reactive TCR,
could result from the ability of LECs to present endogenously
expressed PTAs. One explanation could be the use of the autophagy
pathway by LECs to present endogenous PTAs through MHCII mole-
cules. This hypothesis would be in accordance with previous results
obtained in the thymic epithelium (Nedjic et al, 2008; Aichinger et al,
2013). Future experiments in the laboratory will use mice genetically
deﬁcient for autophagy to ﬁrmly demonstrate the implication of this
pathway in the ability of the different LNSC subsets to present PTAs
through MHCII molecules and to alter the Treg compartment. Our
experiments do not rule out another possible mechanism of action by
which MHCII expression in LNSC may support T-cell inactivation in an
Ag-independent fashion. MHCII is a natural ligand for the molecule
lymphocyte activation gene 3 (LAG-3), expressed on activated T cells
and can be induced by IFN-γ stimulation. This immune checkpoint has
an inhibitory role for LAG-3 in controlling both CD4 and CD8 T-cell
proliferation in vitro and in vivo (Workman et al, 2004; Grosso et al,
2007). In addition, LAG-3 expression on Tregs has been shown to be
important for their suppressive function (Grosso et al, 2007; Okamura
et al, 2009). Moreover, the co-expression of LAG-3 with the inhibitory
receptor PD-1 on exhausted T cells or Tregs correlates with a greater
state of effector T-cell exhaustion and the suppressive function of
Tregs. The relative contribution of both Ag-dependent and/or Ag-
independent pathways remains to be addressed.
In conclusion, our work identiﬁes novel in vivo functions of MHCII
expression by LNSCs in the maintenance of peripheral T-cell tol-
erance by inhibiting autoreactive T cells. We also deﬁne the LECs as
important MHCII expressing cells supporting Treg homeostasis.
Materials and Methods
Mice and treatments
C57BL/6 WT mice were purchased from Charles River. pIV−/−
(Waldburger et al, 2003), Ciita−/− and K14tgpIVKO (Laufer et al, 1996),
and Rag2−/− (Jackson Laboratories) Prox-1-CreERT2 MHCIIﬂmice have
been previously described (Bazigou et al, 2011). To selectively
abrogate MHCII expression in LECs, Prox-1-CreERT2 MHCIIﬂ/ﬂ (and
MHCIIﬂ/ﬂ control) mice were injected with tamoxifen (i.p) twice a day
for four consecutive days (2 mg/mice/d). 2 wk after the last in-
jection, mice were treated with IFN-γ and FTY720 as described
below. These mouse strains are on a C57BL/6 background and were
housed and maintained under SPF conditions at the Geneva
Medical School animal facility and under EOPS conditions at
Charles River, France. All animal husbandry and experiments were
approved by and performed in accordance with guidelines from the
Animal Research Committee of the University of Geneva. Geno-
typing was carried out by using PCR on ear biopsies with the Phire
Tissue Direct PCR Master Mix (F170L; Thermo Fisher Scientiﬁc). When
indicated, IFN-γ (Peprotech) was injected subcutaneously (both
ﬂanks and neck, 1 μg/50 μl), and FTY720 (Sigma-Aldrich) (20 μg) was
injected every day for 6 d before the experiment. Mice from each
group were randomized before treatments.
LNSC and cell tissue isolation
LNSCs were obtained as previously described (Dubrot et al, 2014). In
brief, total skin or skin-draining LNs from individual or 10–15 pooled
mice were cut into small pieces and digested in RPMI containing
1 mg/ml collagenase IV (Worthington Biochemical Corporation),
40 μg/ml DNase I (Roche), and 2% FBS. Undigested cells were
further digested with 1 mg/ml collagenase d, and 40 μg/ml DNase I
(Roche). The reaction was stopped by addition of 5 mM EDTA and
10% BSA. Samples were further disaggregated through a 70-μm cell
strainer and blocked with anti-CD16/32 antibody. Single-cell sus-
pensions were negatively selected using CD45 microbeads and a
magnetic bead column separation (Miltenyi Biotec).
Cells from LN, the spleen, the SC, and SGs were isolated by
digesting organ fragments with an enzymatic mix containing col-
lagenase D (1 μg/ml) and DNAse I (10 μg/ml) (Roche) in HBSS [14].
For SC and SG, single-cell suspensions were further centrifuged
through a discontinuous 30:70% percoll (Invitrogen) gradient. T cells
were further analysed by ﬂow cytometry.
Small intestines were excised and transferred into PBS 2% FCS.
Peyer’s patches and adipose tissue were carefully removed. The
small intestines were cut longitudinally and cleaned of faecal
content. The small intestines were next incubated in RPMI con-
taining 10% FCS, 2 mM EDTA, and 1 mM DTT for 30 min at 37°C in a
shaking incubator to remove epithelial cells, the supernatant being
discarded. The remaining tissue was digested twice in RPMI con-
taining 1 mg/ml of collagenase D (Roche) for 30 min at 37°C in a
shaking incubator. Cells were recovered from the supernatant and
ﬁltered through a 70-μm cell strainer.
Antibodies, ﬂow cytometry, and cell sorting
Anti-gp38 (8.1.1), anti-CD31 (390), anti-CD11c (N418), anti-CD44
(IM7), and anti-IAb (AF6.120.1) mAbs were from BioLegend. Anti-
CD45 (30F11), anti-CD16/32 FcyRIII (2.4G2), anti-I-Ad/I-Ed (2G9),
anti-IFNγR (GR20), and H2-M (2E5A) were from BD. Anti-CD19 (1D3),
anti-CD8 (53–6.7), anti-CD4 (GK1.5), anti-CD11b (M1/70), anti-CD62L
(MEL-14), anti-PDCA-1 (eBio927), anti-PD-1 (J43), anti-IFN-γ (XMG1.2),
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anti-IL-17 (eBio17B7), and anti-Foxp3 (FJK-16s) were from eBio-
science. Anti-EpCAM (caa7-9G8) and anti-Ly5.1 (6C3) were from
Miltenyi Biotec.
For LNSC ﬂow cytometry sorting, enriched CD45neg cells were
stained with mAbs against CD45, gp38, and CD31. In some experi-
ments, cells were also stained with mAbs against MHCII or isotype
control as indicated. For cTEC and mTEC sorting, enriched CD45neg
cells were stained with mAbs against CD45, EpCAM, and Ly5.1.
Intracellular cytokine stainings were carried out with the Cytoﬁx/
Cytoperm kit (BD) for IFN-γ and IL-17 staining. Foxp3 staining was
performed with the eBioscience kit, according to manufacturer’s
instructions. For IFN-γ and IL-17 staining, LN cells were cultured in
RPMI containing 10% heat-inactivated fetal bovine serum, 50 mM
2-mercaptoethanol, 100 mM sodium pyruvate, and 100 μM penicillin/
streptomycin at 37°C and 5% CO2. Cells were stimulated for 18 h with
PMA/ionomycin and Golgi stop solution (BD) was added during the
last 4 h of culture before the staining.
Cells were either acquired on a Gallios or sorted using a
MoFlowAstrios (Beckman Coulter), and analysed using FlowJo (Tree
Star) or Kaluza softwares.
Immunoﬂuorescence microscopy
Mice were transcardiacally perfused with PBS, and intestines were
ﬁxed in paraformaldehyde before inclusion in parafﬁn. Preserved
organs were cut into 7-μm-thick sections and deparafﬁnised in
xylene–ethanol. Ag retrieval was performed in citrate buffer. Sec-
tions were then stained using labelled antibodies against CD45 (30-
F11) and CD3 (17A2) and DAPI (Sigma-Aldrich) counter-staining.
Sections were mounted with Mowiol ﬂuorescent mounting me-
dium (EMD). Images were acquired with a confocal microscope (LSM
700; Carl Zeiss Inc. and SP5; Leica).
Skin LNs from untreated mice or mice treated with IFN-γ and
FTY720 were frozen in OCT medium. 10-μm-thick sections were cut
and ﬁxed with paraformaldehyde 4% for 20 min. After washing and
permeabilization, the sections were stained overnight at 4°C using
a rabbit anti-Lyve-1 antibody (Reliatech GmbH). Secondary staining
was performed using a Alexaﬂuor546-labelled donkey anti-rabbit
antibody, Alexaﬂuor488-labelled anti-Foxp3 (150D) antibodies and
eF660-Ki67 (SolA15), for 2 h at room temperature. After DAPI (Sigma-
Aldrich) staining, sections were mounted with Mowiol ﬂuorescent
mounting medium (EMD). Images were acquired with a confocal
microscope (LSM 700; Carl Zeiss Inc. and SP5; Leica). Tregs in
“close proximity” (<5 μm) of LECs were quantiﬁed as proliferating
(Ki67+Foxp3+) or non-proliferating (Foxp3+) cells, and the ratio of
proliferating Tregs was calculated. At least 20 images/condition
were quantiﬁed.
Treg suppression assay
In vitro Treg suppressive assays were performed as follows: CD4+
CD25hi T cells (Treg) were puriﬁed by ﬂow cytometry from total skin
LNs of 18-mo-old K14tgpIVKO and K14tg control mice and cultured at
the indicated ratio with 2 × 105 proliferation dye-labeled naive CD4+
CD25neg T cells in the presence of bone marrow–derived DC and
anti-CD3 antibodies. Labeled T-cell proliferation was assessed by
ﬂow cytometry after 5 d of co-culture.
T-cell adoptive transfer into Rag22/2 recipients
LN and spleen of donor mice were harvested, and T cells were
negatively selected from the cell suspension using a PAN T isolation
kit (Mylteniy biotec) according to the manufacturer’s instructions.
Purity generally exceeded 95%. 2–5 × 106 T cells were injected in-
travenously into Rag2−/− mice. Recipient mice were randomized
before transfer and co-housed during the experiment.
RNA isolation and quantitative RT-PCR
Total RNA was isolated using Tri-Reagent (Ambien) from sorted
cells. cDNA was synthesized using random hexamers and M-MLV
reverse transcriptase (Promega). PCRs were performed with the
CFX Connect real-time PCR detection system and iQ SYBR green
super mix (Bio-Rad Laboratories). The results were normalized
with GAPDH or 60S ribosomal protein L32 mRNA expression and
quantiﬁed with a standard curve generated with serial dilutions of
a reference cDNA preparation. Primer sequences: I-Ab forward, 59-
CTG TGG TGG TGG TGA TGG T-39 and reverse, 59-CGT TGG TGA AGT AGC
ACT CG-39. H2-Mα forward, 59-CTCGAAGCATCTACACCAGTG-39 and re-
verse, 59-TCCGAGAGCCCTATGTTGGG-39. K14 orward, 59-AGG GAG AGG
ACG CCC ACC TT-39 and reverse, 59- CCT TGG TGC GGA TCT GGC GG-39
Lysate preparation and immunoblotting
Tissues were homogenized in T-PER tissue protein extraction re-
agent (Thermo Fisher Scientiﬁc) supplemented with a cocktail of
protease inhibitors (Complete, Roche). Protein extracts were in-
cubated at 95°C for 5 min with of 4× SDS–PAGE–loading buffer
(250 mmol Tris–HCl at pH = 6.8, 40% glycerol, 8% SDS, 0.57 mol
β-mercaptoethanol, and 0.12% bromophenol blue). Equal amounts
of protein were run on 12% SDS–PAGE gels and transferred onto a
polyvinylidene diﬂuoride membrane (Hybond-P; Amersham Bio-
sciences). Sera from K14tgpIVKO or control mice were visualized with
HRP-conjugated goat anti-mouse IgG (Bio-Rad Laboratories) and
the ECL WesternBright Sirius (advansta).
Statistical analysis
Statistical signiﬁcance was assessed by the two-tailed unpaired
t test or two-way Anova, and Log-rank test using Prism software
(GraphPad).
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